PMC:7247521 / 45008-45200 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"791","span":{"begin":135,"end":144},"obj":"Gene"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" 1600 mg/kg, thus may suggesting safety and efficacy of QFPD. Combined with molecular docking results, 4 specific ingredients (M3, S1, X2 and O2) and 5 common ingredients (MS1, MX16, SX1, WO1 "}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T403","span":{"begin":131,"end":133},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T404","span":{"begin":172,"end":175},"obj":"http://purl.obolibrary.org/obo/CLO_0007875"},{"id":"T405","span":{"begin":172,"end":175},"obj":"http://purl.obolibrary.org/obo/CLO_0052410"}],"text":" 1600 mg/kg, thus may suggesting safety and efficacy of QFPD. Combined with molecular docking results, 4 specific ingredients (M3, S1, X2 and O2) and 5 common ingredients (MS1, MX16, SX1, WO1 "}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T355","span":{"begin":127,"end":129},"obj":"Chemical"},{"id":"T357","span":{"begin":142,"end":144},"obj":"Chemical"}],"attributes":[{"id":"A355","pred":"chebi_id","subj":"T355","obj":"http://purl.obolibrary.org/obo/CHEBI_51083"},{"id":"A356","pred":"chebi_id","subj":"T355","obj":"http://purl.obolibrary.org/obo/CHEBI_53453"},{"id":"A357","pred":"chebi_id","subj":"T357","obj":"http://purl.obolibrary.org/obo/CHEBI_15379"}],"text":" 1600 mg/kg, thus may suggesting safety and efficacy of QFPD. Combined with molecular docking results, 4 specific ingredients (M3, S1, X2 and O2) and 5 common ingredients (MS1, MX16, SX1, WO1 "}

    LitCovid-PD-GlycoEpitope

    {"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T9","span":{"begin":188,"end":191},"obj":"GlycoEpitope"}],"attributes":[{"id":"A9","pred":"glyco_epitope_db_id","subj":"T9","obj":"http://www.glycoepitope.jp/epitopes/AN0690"}],"text":" 1600 mg/kg, thus may suggesting safety and efficacy of QFPD. Combined with molecular docking results, 4 specific ingredients (M3, S1, X2 and O2) and 5 common ingredients (MS1, MX16, SX1, WO1 "}